Sector-wise IPOs
Pharma & Healthcare IPOs
Mainboard and SME issues from the Pharma & Healthcare sector, and how they performed on listing.
- IPOs
- 46
- 33 Mainboard · 13 SME
- Total issue size
- ₹43,057 Cr
- 46 listed so far
- Avg. listing gain
- +18.4%
- 80% opened above issue price
| Company | Listing date | Issue size | Issue price | State | Subscribed | Listing gain | Current gain |
|---|---|---|---|---|---|---|---|
Paras Healthcare Mainboard | 28 Oct 2026 | ₹1,450 Cr | ₹693 | Haryana | 2.23x | +3.90% | +35.11% |
Sahajanand Medical Technologies Mainboard | 23 Oct 2026 | ₹475.48 Cr | ₹344 | Gujarat | 14.2x | +7.89% | +55.22% |
Fusion CX Mainboard | 22 Oct 2026 | ₹702 Cr | ₹289 | West Bengal | 4.45x | +5.54% | +5.09% |
Himalaya Nutravedics India BSE SME | 29 Sep 2026 | ₹26.5 Cr | ₹106 | Telangana | 2.24x | +11.32% | +60.24% |
Symbiotec Pharmalab Mainboard | 1 Sep 2026 | ₹1,757 Cr | ₹988 | Madhya Pradesh | 71.26x | 0.00% | +63.09% |
ABH Healthcare NSE SME | 1 Sep 2026 | ₹34.98 Cr | ₹102 | Punjab | 1.42x | -2.94% | -61.18% |
Credent Connect N Care NSE SME | 20 Aug 2026 | ₹93.9 Cr | ₹189 | Delhi | 142.38x | +90.00% | +116.40% |
Pramodini Medicare NSE SME | 19 Aug 2026 | ₹69.04 Cr | ₹118 | Andhra Pradesh | 3.66x | +1.69% | -10.72% |
Molbio Diagnostics Mainboard | 17 Aug 2026 | ₹939.7 Cr | ₹807 | Goa | 70.26x | +21.44% | +85.03% |
Manipal Health Enterprises Mainboard | 5 Aug 2026 | ₹9,275.22 Cr | ₹590 | Karnataka | 4.92x | +10.51% | +15.49% |
Avience Biomedicals NSE SME | 25 Jun 2026 | ₹30.24 Cr | ₹208 | Delhi | 385.4x | +90.00% | +20.55% |
Hexagon Nutrition Mainboard | 12 Jun 2026 | ₹138.87 Cr | ₹45 | Maharashtra | 53.68x | +7.22% | +29.98% |
Bio Medica Laboratories NSE SME | 29 May 2026 | ₹52 Cr | ₹139 | Madhya Pradesh | 2.31x | -20.00% | +7.91% |
Q-Line Biotech NSE SME | 29 May 2026 | ₹251 Cr | ₹343 | — | 102.49x | +31.78% | +42.36% |
Goldline Pharmaceutical BSE SME | 19 May 2026 | ₹12 Cr | ₹43 | Maharashtra | 781.85x | +38.95% | -31.93% |
Sai Parenteral's Mainboard | 2 Apr 2026 | ₹409 Cr | ₹392 | Telangana | 1.08x | +2.04% | +26.75% |
Speciality Medicines BSE SME | 30 Mar 2026 | ₹29 Cr | ₹124 | Gujarat | 2.19x | 0.00% | +36.61% |
Gaudium IVF Mainboard | 27 Feb 2026 | ₹165 Cr | ₹79 | Delhi | 7.27x | +5.06% | +34.11% |
Accretion Nutraveda BSE SME | 4 Feb 2026 | — | ₹129 | Gujarat | 1.77x | +48.06% | +170.39% |
Hannah Joseph Hospital BSE SME | 1 Feb 2026 | — | ₹70 | Tamil Nadu | 1.51x | -7.14% | +52.71% |
KRM Ayurveda NSE SME | 27 Jan 2026 | — | ₹135 | Delhi | 74.43x | +27.48% | +70.30% |
| 7 Jan 2026 | — | ₹90 | Delhi | 350.49x | 0.00% | -35.56% | |
Gujarat Kidney & Super Speciality Mainboard | 30 Dec 2025 | ₹250.8 Cr | ₹114 | Gujarat | 5.21x | +5.26% | +36.57% |
Park Medi World Mainboard | 17 Dec 2025 | ₹920 Cr | ₹162 | Telangana | 8.1x | -1.98% | +57.77% |
Nephrocare Health Services Mainboard | 17 Dec 2025 | ₹871.05 Cr | ₹460 | Telangana | 13.96x | +6.52% | +41.53% |
Corona Remedies Mainboard | 15 Dec 2025 | ₹655.37 Cr | ₹1,062 | Maharashtra | 137.04x | +38.42% | +119.37% |
Sudeep Pharma Mainboard | 28 Nov 2025 | ₹895 Cr | ₹593 | Gujarat | 93.72x | +23.10% | +102.14% |
Rubicon Research Mainboard | 16 Oct 2025 | ₹1,378 Cr | ₹485 | Maharashtra | 109.32x | +27.84% | +246.25% |
Amanta Healthcare Mainboard | 9 Sep 2025 | ₹126 Cr | ₹126 | — | 82.6x | +7.14% | +86.09% |
Anlon Healthcare Mainboard | 3 Sep 2025 | ₹121.03 Cr | ₹91 | — | 7.12x | +1.10% | +196.04% |
Anthem Biosciences Mainboard | 21 Jul 2025 | ₹3,395 Cr | ₹570 | — | 67.42x | +26.85% | +64.38% |
Ellenbarrie Industrial Gases Mainboard | 1 Jul 2025 | ₹852.53 Cr | ₹400 | — | 22.47x | +21.50% | -26.94% |
Standard Glass Lining Technology Mainboard | 13 Jan 2025 | ₹410.05 Cr | ₹140 | — | 185.48x | +25.71% | +152.32% |
Senores Pharmaceuticals Mainboard | 30 Dec 2024 | ₹582.11 Cr | ₹391 | — | 96.96x | +53.45% | +200.41% |
Inventurus Knowledge Solutions Mainboard | 19 Dec 2024 | ₹2,497.92 Cr | ₹1,329 | — | 52.68x | +42.96% | +22.96% |
Sai Life Sciences Mainboard | 18 Dec 2024 | ₹3,042.62 Cr | ₹549 | — | 10.27x | +18.40% | +251.33% |
Suraksha Diagnostic Mainboard | 6 Dec 2024 | ₹846.25 Cr | ₹441 | — | 1.27x | -0.68% | -22.52% |
Sagility India Mainboard | 12 Nov 2024 | ₹2,106.4 Cr | ₹30 | — | 3.2x | +3.53% | +46.23% |
Akums Drugs & Pharmaceuticals Mainboard | 6 Aug 2024 | ₹1,856.74 Cr | ₹679 | — | 63.44x | +6.77% | +9.14% |
Kronox Lab Sciences Mainboard | 10 Jun 2024 | ₹130.15 Cr | ₹136 | — | 117.25x | +21.29% | +41.70% |
Indegene Mainboard | 13 May 2024 | ₹1,841.76 Cr | ₹452 | — | 70.3x | +44.91% | +47.39% |
GPT Healthcare Mainboard | 29 Feb 2024 | ₹525.14 Cr | ₹186 | — | 8.52x | +15.59% | -22.68% |
Entero Healthcare Solutions Mainboard | 16 Feb 2024 | ₹1,600 Cr | ₹1,258 | — | 1.56x | -2.33% | +56.49% |
Medi Assist Healthcare Services Mainboard | 23 Jan 2024 | ₹1,171.58 Cr | ₹418 | — | 16.25x | +10.05% | -32.80% |
Innova Captab Mainboard | 29 Dec 2023 | ₹570 Cr | ₹448 | — | 56.33x | +0.92% | +161.70% |
Gandhar Oil Refinery (India) Mainboard | 30 Nov 2023 | ₹500.69 Cr | ₹169 | — | 65.63x | +76.33% | +56.54% |
Industry is assigned by Be IPO Ready from each company's business description and is indicative.
For business owners
Planning a Pharma & Healthcare IPO?
1.Can a Pharma & Healthcare company list on NSE Emerge or BSE SME?
Yes. Pharma & Healthcare businesses list on the SME platforms regularly, as the issues on this page show. Eligibility depends on track record, operating profit, net worth and compliance history rather than on the sector itself.
2.How much do Pharma & Healthcare companies raise in an IPO?
The issue sizes above show the range for recent Pharma & Healthcare IPOs. Your own issue size depends on profits, valuation and the stake you are willing to dilute. Our issue size calculator gives an indicative figure.
3.What do investors look for in a Pharma & Healthcare IPO?
Consistent revenue growth, healthy margins, a clear use of IPO proceeds, low related-party dealings and a credible promoter team. Getting these in order before filing improves both subscription and valuation.
For business owners
In the Pharma & Healthcare business? See what your IPO could look like
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 92130 20393